Mobile

The trial is designed to determine the long-term safety and efficacy of ABP 501 in subjects with moderate to severe rheumatoid arthritis

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-004654-13

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to evaluate the long-term safety and efficacy of ABP 501 in subjects with moderate to severe rheumatoid arthritis.

Critère d'inclusion

  • Moderate to Severe Rheumatoid Arthritis

Liens